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Role of cytokines and chemokines in alcohol-
induced tumor promotion
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Abstract: Excessive chronic alcohol consumption has become a worldwide health problem. The 
oncogenic effect of chronic alcohol consumption is one of the leading concerns. The mechanisms 
of alcohol-induced tumorigenesis and tumor progression are largely unknown, although many 
factors have been implicated in the process. This review discusses the recent progress in this 
research area with concentration on alcohol-induced dysregulation of cytokines and chemokines. 
Based on the available evidence, we propose that alcohol promotes tumor progression by the 
dysregulation of the cytokine/chemokine system. In addition, we discuss specific transcription 
factors and signaling pathways that are involved in the action of these cytokines/chemokines 
and the oncogenic effect of alcohol. This review provides novel insight into the mechanisms 
of alcohol-induced tumor promotion.
Keywords: alcohol, tumor promotion, cytokines, chemokines, transcription factors, signal 
transduction, therapy
Introduction
Alcohol is a tumor promoter.1 Alcohol is involved in tumor promotion by not only 
alcohol itself but also the derivatives of alcohol, such as acetaldehyde and free radicals 
that are generated in the metabolic process. For example, acetaldehyde, proteins, and 
DNA may form adduct, which leads to genetic mutations that induce tumorigenesis. 
Alcohol abuse is defined as intake of alcohol that exceeds 21 units weekly or 3 units 
per day. Alcohol abuse is a major risk factor for tumors, especially the upper gastro-
intestinal tract (oral cavity, pharynx, larynx, and esophagus) tumors, hepatocellular 
carcinoma (HCC), colorectal cancer, and breast cancer.2–6 Furthermore, in many types 
of tumors, including gastrointestinal tract, gynecological, brain, and renal tumors, the 
activity of alcohol dehydrogenase is significantly increased.7
Alcohol exposure also enhances the progression and metastasis of a variety 
of tumors, such as skin, liver, lung, breast, and colon cancers.8–13 Chronic alcohol 
consumption is often associated with poor clinical prognosis.9 However, the underlying 
cellular and molecular mechanisms are complex.
Alcohol consumption is one of the risk factors that correlate with high cancer 
mortality rates,14 and this is mainly because chronic alcohol consumption often 
leads to advanced TNM stages, greater vessel invasion, and poorer prognosis.9 The 
underlying mechanism may be that alcohol consumption activates the expression of 
some cytokines, such as VEGF, MCP-1, and NF-κ B, which are associated with tumor 
progression and metastasis.8–10
This review discusses the current research progress in the cellular and molecular 
mechanisms underlying alcohol-induced tumor promotion. We specifically focus on 
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the role of cytokines and chemokines in alcohol-promoted 
tumor progression and aggressiveness.
Alcohol-induced dysregulation of 
cytokines and chemokines
Cytokines are small molecule proteins with a broad range 
of biological activities. They are normally synthesized and 
secreted by the immune cells, such as monocytes, mac-
rophages, T cells, B cells, and natural killer cells, as well 
as some nonimmune cells, such as endothelial cells and 
fibroblasts. Cytokines regulate cell growth and differentiation 
by binding to the specific receptors and mediate the immune 
response.15,16 Chemokines are chemotactic cytokines that 
mediate the migration and positioning of the target cells.17 
In addition to mediating immune response, chemokines are 
also involved in regulating the embryonic development, 
angiogenesis, and apoptosis. More importantly, chemokines 
are now known to play a vital role in tumorigenesis, tumor 
progression, and metastasis.18,19 The most well-investigated 
cytokines and chemokines include VEGF, MCP-1, TLR, 
and TNF-α. Alcohol exposure affects the cytokine and 
chemokine systems.20–22 Particularly, the effects of alcohol 
on VEGF and MCP-1 receive great attention due to their 
roles in tumorigenesis and progression.
veGF
VEGF is a highly conservative glycoprotein23,24 and plays 
an important role in angiogenesis, invasion of tumors,25,26 
cell proliferation, and vascular permeability.27–29 VEGF is 
significantly upregulated in tumor tissues and positively 
correlated with malignancy.30,31 It is proposed that alcohol 
promotes tumor growth, angiogenesis, and metastasis in 
skin cancer, liver cancer, and breast cancer by increasing 
the VEGF levels.8,32 In addition, oxidative stress and NF-κ B 
mediate the alcohol-induced VEGF upregulation.9 However, 
the exact signaling mechanisms are still largely unknown.
MCP-1
MCP-1, also called CCL2, activates the mononuclear cells 
and macrophages by increasing the intracytoplasmic Ca2+ con-
centration and releasing the superoxide anion and lysozyme.33 
Moreover, many studies also demonstrated that MCP-1 
plays essential roles in tumor microenvironment by regulat-
ing tumor angiogenesis, tumor growth, and metastasis.34–36 
Alcohol exposure upregulates MCP-1 and recruits M2 
macrophages in tumor microenvironment, which, in turn, pro-
motes the growth and metastasis of lung cancer (Figure 1).10 
More importantly, it is reported that alcohol promotes 
the growth and angiogenesis of breast cancer through 
activation of MCP-1 and its receptor CCR2 (Figure 1).11 
Consistent with this idea, antagonists of CCR2 can inhibit 
tumor angiogenesis induced by alcohol.11 Alcohol can also 
promote the migration and invasion of colorectal cancer cells 
(CSCs) by regulating the GSK3β/β-catenin/MCP-1 signaling 
pathway.12 However, the exact mechanisms of how MCP-1 
mediated the effects, ie, alcohol stress-induced tumorigenesis 
and tumor growth, are still unclear.
TLR
TLR is a type I transmembrane receptor and pathogenic 
pattern recognition receptor, which participates in natural 
immunity. TLR plays an important role in cellular immune 
responses.37 Furthermore, some cytokines also regulate stem 
cells. For example, TLR induces NANOG gene expression, 
which is involved in the regulation of tumor-initiating stem-
like cells (TICs).38
Recent studies found that TLR may play an important role 
in alcohol-induced liver cancer by regulating the TICs,38 at 
least partially through Nanog, one of the embryonic stem cell 
markers, which, in turn, regulates the proliferation and differ-
entiation of liver stem/progenitor cells.39 Once activated, the 
proportion of CD133/Nanog-positive cells increased in liver 
cancer.40 Conversely, knocking off TLR genes can prevent 
tumor growth to a certain extent.41 Interestingly, studies 
found that ethanol-treated malignant cells fused to dendritic 
cells (DCs) exposed to TLR stimulation, thus promoting 
Figure 1 Role of veGF and MCP-1 in alcohol-induced tumor growth and 
metastasis. 
Notes: Alcohol exposure upregulates veGF level, thus promoting angiogenesis of 
endothelial cells. Alcohol exposure activates MCP-1 and recruits M2 macrophages, 
which, in turn, promotes the growth and metastasis of cancer cells.
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abnormal cellular immune response, which is thought to be 
an important mechanism of tumor promotion.42
Overall, these data suggested that chronic alcohol stress 
may play an important role in tumor promotion at least 
partially through the TLR/Nanog pathway.
TNF-α
TNF-α is a type II membrane protein, which is mainly 
secreted by the activated mononuclear macrophages and 
could act either as a tumor suppressor or as an oncogene. 
TNF-α plays an antitumor role by inducing apoptosis, inhibit-
ing tumor angiogenesis, and enhancing host immunity.43,44 
TNF-α also acts as an oncogene by upregulating inflammatory 
cytokines, inhibiting apoptosis, and activating multiple sig-
naling pathways, causing tumor-associated gene mutation.45,46 
The increased TNF-α in tumor microenvironment can 
promote tumor cell migration and invasion,47 which is associ-
ated with metastasis, recurrence, and poor prognosis of cancer 
patients.48 More importantly, chronic ethanol exposure can 
upregulate TNF-α, which, in turn, facilities infiltration of 
monocytes/macrophages in liver and, therefore, promotes 
liver lesions. For instance, TNF increased significantly in the 
liver tissue of alcohol-fed mice.49 However, the underlying 
mechanisms of TNF-α variation in alcohol-induced tumor 
promotion need to be further explored.
Alcohol-induced dysregulation of 
transcription factors mediated by 
cytokines and chemokines
Cytokines and chemokines directly or indirectly regulate 
transcription factors, which play key roles in integrating 
the multiple extracellular signaling pathways and regulat-
ing gene expression. The transcription factors known to 
be regulated by cytokines and chemokines include Egr-1, 
AP-1, and STAT.
Alcohol exposure affects the activity of transcription 
factors. Some of these transcription factors are known to be 
involved in the action of cytokines and chemokines as well 
as tumorigenesis/progression.50–53 In the present study, we 
focus on the three transcription factors that are affected by 
alcohol exposure, namely, Egr-1, STAT, and AP-1.
egr-1
Egr-1 is a nuclear transcription factor that is regulated by 
the mitogen-activated protein kinase (MAPK) signaling 
pathway.54 Egr-1 binds to the promoter region of TNF-α 
and increases the sensitivity of liver macrophages.55 Egr-1 
is upregulated in the process of alcoholic cirrhosis.50 
Lipopolysaccharide (LPS)-induced activation of Egr-1 in 
the liver Kupffer cells contributes to the pathogenesis of 
alcoholic liver disease.51 In addition, chronic alcohol expo-
sure also induces Egr-1 to bind to the promoter region of the 
TNF-α and increases the sensitivity of liver macrophages.55 
Alcohol-induced liver cirrhosis may in the long run increase 
the risk of liver carcinogenesis.
Egr-1 also plays an important role in the process of 
tumorigenesis.56 Egr-1 has been found highly expressed in 
gastric cancer and bladder cancer,57,58 and it may upregulate 
invasion and metastasis-related genes, such as matrix metal-
loproteinases (MMP3).59 However, whether alcohol promotes 
tumor metastasis by activating Egr-1 is largely unknown.
STAT
The activity of STAT is regulated by JAK-mediated sig-
nal transduction, which can be activated by cytokines and 
chemokines.60 MAPK/STAT3 signaling pathway increases 
the DNA binding ability of AP-1 through the activation of 
Src kinases, thereby inducing the production of IL-10.61,62
During alcoholic liver injury, STAT3 modulates the 
liver immune response in a cell-type-dependent manner. For 
example, in liver cells, STAT3 exerts a pro-inflammatory role, 
whereas in mononuclear cells and Kupffer cells, STAT3 
plays an anti-inflammatory role.52 In addition, the decreased 
liver regeneration capacity of patients with alcoholic cirrhosis 
is related to the decreased activity of STAT3, revealing a 
positive correlation between STAT3 and liver regeneration 
ability.53 Nevertheless, it is still unclear how ethanol exposure 
regulates STAT3 in liver cancer.
AP-1
AP-1 is a transcription factor that belongs to the leucine 
zipper protein family.63 AP-1 responds to cytokines by regu-
lating the expression of a number of genes related to carcino-
genesis and tumor progression. AP-1 and other transcription 
factors, including STAT3, SP-1, and SP-3, are all involved 
in LPS-induced production of IL-10 in monocytes and 
T cells.64–67 Meanwhile, it has been demonstrated that alco-
hol exposure activates the Src/MAPK/STAT3 signaling 
pathway and increases the DNA binding ability of AP-1, 
thereby inducing the production of IL-10.61 In the context 
of liver injury, alcohol exposure enhances the sensitivity of 
liver macrophages via upregulating AP-1 and increasing 
the expression of CD14.68 Alcohol exposure can also acti-
vate AP-1 in a protein kinase C (PKC)-dependent manner 
and enhance proliferation ability of liver cells by increas-
ing the expression of c-Jun and c-Fos in the liver cells.69 
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Alcohol-induced liver injury may also in the long run 
increase the risk of liver carcinogenesis.
Alcohol-induced dysregulation of 
signaling pathways in the action of 
cytokines and chemokines
There are a number of signaling pathways that are regulated 
by cytokines and chemokines and play an important role in 
tumorigenesis and progression. On the other hand, these 
signaling pathways can also modulate the expression of 
cytokines and chemokines. The most important signaling 
pathways involved in the action of cytokines and chemok-
ines are NF-κ B-TNF-α signaling pathway, MAPK signaling 
pathway, and Wnt/β-catenin signaling pathway.
Alcohol can cause the dysregulation of some signaling 
pathways that are involved in the action of cytokines, 
chemokines, tumorigenesis, and progression. In the present 
review, we discuss the three most important signaling 
pathways affected by alcohol exposure.
NF-κ B-TNF-α signaling pathway
TNF-α is involved in multiple signaling pathways and can 
activate NF-κ B which, in turn, also participates in regulating 
TNF-α.70 LPS-induced oxidative stress activates NF-κ B, 
increasing TNF-α production in Kupffer cells. LPS activates 
Kupffer cells and induces the production of superoxides that 
activate NF-κ B. Once activated, NF-κ B is translocated to 
the nucleus and regulates the expression of several critical 
inflammatory cytokines, particularly TNF-α.71 Blocking the 
activation of NF-κ B markedly decreases cytokine produc-
tion and ameliorates inflammation and necrosis.72 It has 
been reported that alcohol-induced liver damage is associ-
ated with the activation of the NF-κ B signaling pathway as 
well as the high expression of pro-inflammatory cytokines 
and upregulation of TLR3 and TLR7.73 It is believed that 
alcohol exposure regulates the inflammatory response of 
hepatic macrophages at least partially through the NF-κ B 
signaling pathway. Alcohol can activate the NF-κ B signaling 
pathway by affecting its nuclear localization, formation of 
NF-κ B p65/p50 dimmers, and DNA binding activity.71,73,74 
In the mouse model of alcohol-induced liver injury, alcohol 
consumption causes a significant increase in DNA binding 
activity of NF-κ B in the liver.73
Our recent study demonstrated that alcohol exposure 
activates the NF-κ B signaling pathway and upregulates 
its target cytokines and chemokines, VEGF and MCP-1, 
which promote angiogenesis, growth, and metastasis of liver 
cancer cells.9
MAPK signaling pathway
MAPK signaling pathway is involved in mediating the 
tumorigenesis and metastasis.75 Cytokines and chemokines 
can activate three members of the MAPK family, namely, 
ERK1/2, p38 MAPK, and JNK/SAPK.76,77 Among them, the 
p38 MAPK pathway is required for the induction of TNF-α-
RNA-binding activity and mediates stabilization of TNF-α 
mRNA in myeloid cells stimulated with bacterial LPS.78 
Alcohol affects the MAPK family and activates the three 
members of this family, namely ERK, p38 MAPK, and JNKs. 
A recent study showed that alcohol promotes malignant 
progression of breast cancer by activating the p38γ MAPK/
RhoC signaling pathway.79 Alcohol activates p38 MAPK 
in mononuclear cells, which generates anti-inflammatory 
cytokines such as IL-10.80 Similarly, it is reported that alcohol 
stimulates the liver macrophages to produce TNF-α through 
the activation of ERK1/2.81 Alcohol exposure also activates 
Src/MAPK/STAT3 and increases the binding ability of 
AP-1.61 Meanwhile, JNK was activated by alcohol in breast 
cancer cells and required for alcohol-induced cell invasion.82 
Since MAPKs play an important role in tumorigenesis and 
progression, the effect of alcohol on MAPKs has a significant 
impact on tumor promotion.
wnt/β-catenin signaling pathway
Wnt/β-catenin signaling pathway regulates tumor growth 
and metastasis83 as well as self-renewal and differentiation 
of cancer stem cells.84 Some cytokines are implicated in 
the regulation of Wnt/β-catenin signaling. On the one hand 
cytokine such as TNF-α activates Wnt/β-catenin signal-
ing, on the other hand Wnt/β-catenin signaling also affects 
specific cytokines.34,85,86 For example, IL-1β and TNF-α 
induced rat nucleus pulposus cells apoptosis by activating 
the caveolin-1/Wnt/β-catenin signaling pathway.85 TNF-α-
induced NF-κ B activation inhibits osteogenesis of mesen-
chymal stem cells by targeting Wnt/β-catenin signaling.86 
Furthermore, MCP-1 is a target of the β-catenin/TCF/LEF 
pathway in breast tumor cells and plays a key role in breast 
tumor progression.34
Recent studies demonstrated that alcohol activates the 
Wnt/β-catenin signaling pathway and promotes malignant 
proliferation of cancer cells and tumor formation in the 
liver.87,88 Our previous study found that the Wnt/β-catenin 
pathway mediates alcohol-stimulated MCP-1 gene transcrip-
tion and enhances CSC metastasis.12 Whether the Wnt/β-
catenin signaling pathway is activated by alcohol stress in 
other tumors, such as breast cancer, colon cancer, and the 
underlying molecular mechanisms are undiscovered.
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Cytokines and chemokines as 
potential therapeutic targets
Cytokines and chemokines are potential therapeutic targets 
for the treatment of alcohol-induced tumor promotion as 
well as other alcohol-related diseases. They may be used 
as biomarkers for alcohol-induced organ damage. For 
example, MCP-1 levels in cerebrospinal fluid, together with 
gamma glutamyltransferase (GGT) and aspartate amin-
otransferase/glutamic oxaloacetic transaminase (AST/GOT) 
in peripheral blood, are indicators of clinical alcoholic 
hepatitis in alcoholics.89 Recent studies showed that blocking 
NF-κ B-regulated MCP-1 and VEGF expression inhibits 
alcohol-induced tumor formation ability of liver cancer 
cells.9 Similarly, blocking Wnt/β-catenin signaling inhibits 
alcohol-stimulated MCP-1 expression and alleviates alcohol-
induced invasion of colon cancer cells.12 These studies suggest 
that targeting cytokines and chemokines may be a potential 
therapeutic strategy for cancer treatment, particularly in the 
context of alcohol-induced tumor promotion.
Conclusion
•	 Excessive alcohol consumption is a risk factor for cancer. 
Alcohol promotes tumorigenesis, progression, and 
metastasis.
•	 Alcohol causes dysregulation of cytokines and chemok-
ines, which may mediate alcohol-induced tumor promo-
tion. Alcohol may also affect transcription factors and 
signaling pathways that regulate the expression/function 
of cytokines and chemokines.
•	 Systematic screening of cytokines and chemokines that 
are affected by alcohol during tumorigenesis and cancer 
progression is necessary for providing more insight into 
the role of cytokines and chemokines in alcohol-induced 
tumor promotion. Targeting cytokines and chemokines 
could be a potential therapeutic strategy for cancer 
treatment, particularly in the context of alcohol-induced 
tumor promotion/progression.
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